Search

Your search keyword '"Tamoxifen -- Reports"' showing total 585 results

Search Constraints

Start Over You searched for: Descriptor "Tamoxifen -- Reports" Remove constraint Descriptor: "Tamoxifen -- Reports"
585 results on '"Tamoxifen -- Reports"'

Search Results

51. Findings from J. Chollet and Co-Authors Reveals New Information on Breast Cancer (Vaginal tamoxifen for treatment of vulvar and vaginal atrophy: Pharmacokinetics and local tolerance in a rabbit model over 28 days)

52. Reports Outline Breast Cancer Study Findings from Ontario Institute for Cancer Research [Breast Cancer Index and Prediction of Benefit from Extended Endocrine Therapy in Breast Cancer Patients Treated in the Adjuvant Tamoxifen - To Offer More? ...]

53. Researchers at School of Medical Science and Technology Report New Data on Breast Cancer (Lactate Dehydrogenase a Regulates Autophagy and Tamoxifen Resistance In Breast Cancer)

54. Findings on Antineoplastics Detailed by M.A. Chiacchio and Co-Authors (1,2,4-Oxadiazole-5-ones as analogues of tamoxifen: synthesis and biological evaluation)

55. Researchers from University of Edinburgh Discuss Findings in Antineoplastics (Tamoxifen- and Mifepristone-inducible Versions of Crispr Effectors, Cas9 and Cpf1)

56. New Breast Cancer Study Findings Recently Were Reported by Researchers at National Yang Ming University (Set Overexpression Is Associated With Worse Recurrence-free Survival In Patients With Primary Breast Cancer Receiving Adjuvant Tamoxifen ...)

57. Findings in Xenografts Reported from S.P. Govek and Co-Researchers (Selective estrogen receptor degraders with novel structural motifs induce regression in a tamoxifen-resistant breast cancer xenograft)

58. Findings from F. Fus and Co-Authors in the Area of Breast Cancer Reported (Intracellular Localization of an Osmocenyl-Tamoxifen Derivative in Breast Cancer Cells Revealed by Synchrotron Radiation X-ray Fluorescence Nanoimaging)

59. Report Summarizes Breast Cancer Study Findings from T. Ruhstaller and Co-Researchers (Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG ...)

60. Research from Abigail Wexner Research Institute Has Provided New Study Findings on Silicone Implant (Tamoxifen reduces silicone implant capsule formation in a mouse model)

63. Reports Outline Tamoxifen Findings from Xi'an Jiaotong University (A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer)

64. Studies from National Cancer Center Research Institute Have Provided New Data on Biological Markers (A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study)

65. Studies from University of Hong Kong in the Area of Breast Cancer Reported (BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen-Resistant Breast Cancer)

66. Researchers from Netherlands Cancer Institute Report on Findings in Breast Cancer (Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot)

67. Investigators from Department of Psychiatry Report New Data on Brain Injury (Tamoxifen-induced knockdown of the mitochondrial calcium uniporter in Thy1-expressing neurons protects mice from hypoxic/ischemic brain injury)

68. New Findings Reported from Bilkent University Describe Advances in Antineoplastics (Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer)

69. New Findings from Nankai University Describe Advances in Breast Cancer (Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer)

70. Reports from Zhejiang University Provide New Insights into Breast Cancer (KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer)

72. First Affiliated Hospital of China Medical University Reports Findings in Breast Cancer (The role of AKR1 family in tamoxifen resistant invasive lobular breast cancer based on data mining)

73. Reports Outline Breast Cancer Study Findings from Institute Gustave Roussy (Treatment adoption and relative effectiveness of aromatase inhibitors compared to tamoxifen in early breast cancer: A multi-institutional observational study)

74. Researchers at New York University School of Medicine Report New Data on Estrogen (Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming)

75. Researchers at Roswell Park Cancer Institute Describe Findings in Biomarkers (Tamoxifen sensitivity-related microRNA-342 is a useful biomarker for breast cancer survival)

77. Reports Outline Breast Cancer Findings from Chulalongkorn University (Salinomycin overcomes acquired tamoxifen resistance through AIB1 and inhibits cancer cell invasion in endocrine resistant breast cancer)

78. Reports from Samsung Medical Center Describe Recent Advances in Breast Cancer (Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells)

79. Reports Outline Stilbenes Study Results from National Institute of Health Sciences (Tamoxifen and Fulvestrant Hybrids Showed Potency as Selective Estrogen Receptor Down-Regulators)

80. New Breast Cancer Study Findings Have Been Reported by Researchers at Chulalongkorn University (Salinomycin overcomes acquired tamoxifen resistance through AIB1 and inhibits cancer cell invasion in endocrine resistant breast cancer)

81. New Breast Cancer Study Findings Have Been Reported by Investigators at Institute for Biochemistry (Overexpression of the erythropoietin receptor in RAMA 37 breast cancer cells alters cell growth and sensitivity to tamoxifen)

82. Findings from German Cancer Research Center Yields New Findings on Breast Cancer (The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ER alpha-negative breast cancer)

83. Investigators from Institute of Cancer Research Report New Data on Carcinomas (The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole)

84. Findings from Dana-Farber Cancer Institute Yields New Data on Breast Cancer (Embryonic transcription factor SOX9 drives breast cancer endocrine resistance)

85. Reports from University of Louisville Describe Recent Advances in Breast Cancer (Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells)

86. Findings from Netherlands Cancer Institute Yields New Data on Breast Cancer (Estrogen receptor alpha wields treatment-specific enhancers between morphologically similar endometrial tumors)

87. Researchers at Shandong University Report New Data on Breast Cancer (Huaier extract synergizes with tamoxifen to induce autophagy and apoptosis in ER-positive breast cancer cells)

88. Studies from A. Schultink and Co-Researchers Yield New Data on Breast Cancer (An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome)

89. Researchers from Xi'an Jiao Tong University Report on Findings in Breast Cancer (Simvastatin suppresses the DNA replication licensing factor MCM7 and inhibits the growth of tamoxifen-resistant breast cancer cells)

90. Researchers from Karolinska Institute Describe Findings in Breast Cancer (Blockade of the Hedgehog pathway downregulates estrogen receptor alpha signaling in breast cancer cells)

91. Researchers at Department of Pharmacy Report Findings in Breast Cancer (Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases)

92. Researchers from University of Sheffield Report on Findings in Intracellular Calcium-Sensing Proteins (High-affinity tamoxifen analogues retain extensive positional disorder when bound to calmodulin)

93. Researchers' Work from University Indonesia Focuses on Science and Technology (Analysis of tamoxifen and its metabolites in dried blood spot and volumetric absorptive microsampling: comparison and clinical application)

94. New Antineoplastics Findings from University of La Laguna Described (* * FLTX2* * : A Novel Tamoxifen Derivative Endowed with Antiestrogenic, Fluorescent, and Photosensitizer Properties)

96. Reports from Ohio State University Describe Recent Advances in Breast Cancer (Overcoming Tamoxifen Resistance of Human Breast Cancer by Targeted Gene Silencing Using Multifunctional pRNA Nanoparticles)

97. Findings on Breast Cancer Discussed by Investigators at Chulalongkorn University (Plumbagin Enhances Tamoxifen Sensitivity and Inhibits Tumor Invasion in Endocrine Resistant Breast Cancer through EMT Regulation)

98. Investigators from People's Hospital Report New Data on Breast Cancer (Exosomes mediated transfer of IncRNA UCA1 results in increased tamoxifen resistance in breast cancer cells)

99. Presurgical endocrine therapy less toxic than chemotherapy for ER-positive breast cancer

Catalog

Books, media, physical & digital resources